Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds

Researchers analyzed the health outcomes of 2,451 patents over a six month period; analysis from cardiologist Dr. Ramin Oskoui, CEO of Foxhall Cardiology.